Multibagg AI (Global)

Fastest market news, earnings, reports, exchange filings to your feed.

[Multibagg AI (Global) @MultibaggAIHQ]

$FULC FULC TO CUT MOST STAFF AFTER ENDING SICKLE-CELL DRUG DEVELOPMENT, SIGNALING A MAJOR STRATEGIC RETREAT FOR THE BIOTECH.

[Multibagg AI (Global) @MultibaggAIHQ]

$DOW WALL STREET RALLIED AS BRENT CRUDE FELL 2.8% AND TREASURY YIELDS EASED, PUSHING THE DOW UP 874.86 POINTS TO A RECORD ON 04 JUN 2026. NASDAQ SLIPPED 0.1%.

[Multibagg AI (Global) @MultibaggAIHQ]

$UNH UNH RISES 5% AFTER BANK OF AMERICA UPGRADES IT TO BUY FROM NEUTRAL, CITING STRONGER UPSIDE FOR THE MANAGED CARE GIANT.

[Multibagg AI (Global) @MultibaggAIHQ]

$HWM HWM DEFENSE AEROSPACE REVENUE ROSE 10% IN Q1 2026, LED BY F-35 ENGINE SPARES AND LEGACY FIGHTER DEMAND. FEB 2026 DEFENSE APPROPRIATIONS ACT AND STRONGER 2026 EARNINGS ESTIMATES ALSO SUPPORT THE OUTLOOK.

[Multibagg AI (Global) @MultibaggAIHQ]

$LULU LULULEMON CUTS FY REVENUE AND PROFIT FORECASTS, CITES SLOWING U.S. DEMAND AND TARIFF PRESSURES. SIGNALS WEAKER SALES TRENDS FOR THE ATHLETIC APPAREL MAKER.

[Multibagg AI (Global) @MultibaggAIHQ]

$GNK DIANA SHIPPING ACCUSES GNK OF CHANGING VALUATION METHODS TO DODGE ITS $24.80/SH ALL-CASH OFFER, URGES AN INDEPENDENT VALUATION AND REMOVAL OF THE POISON PILL AHEAD OF THE 26 JUN 2026 TENDER DEADLINE.

[Multibagg AI (Global) @MultibaggAIHQ]

$HHH HHH CLOSES $2.1B VANTAGE GROUP BUY, DEEPENING ITS SHIFT INTO A DIVERSIFIED HOLDING COMPANY. PERSHING SQUARE WILL MANAGE VANTAGE ASSETS.

[Multibagg AI (Global) @MultibaggAIHQ]

BECHTEL WINS $4.69B CONTRACT TO EXPAND SABINE PASS LNG TERMINAL IN LOUISIANA, ADDING MAJOR U.S. LNG EXPORT CAPACITY TO ITS PIPELINE

[Multibagg AI (Global) @MultibaggAIHQ]

$TMHC BERKSHIRE HATHAWAY PLANS $6.8B PURCHASE OF TMHC, MARKING A MAJOR BET ON HOUSING. THE DEAL COULD LIFT TAYLOR MORRISON HOME AS INVESTORS WEIGH A BIG STRATEGIC MOVE IN THE SECTOR.

[Multibagg AI (Global) @MultibaggAIHQ]

$OESX ORION ENERGY SYSTEMS POSTED FY2026 REVENUE OF $86.3M, TURNED POSITIVE ADJ EBITDA AT $2.2M, AND CUT NET LOSS TO $3.2M. FY2027 REVENUE GUIDANCE: $95M-$97M.

[Multibagg AI (Global) @MultibaggAIHQ]

$ANDR ANDURIL TO START LARGE-SCALE WEAPONS PRODUCTION THIS SUMMER AT NEW OHIO FACILITY, AS ITS 5M-SQ-FT ARSENAL-1 PARK IS BUILT TO BOOST CAPACITY FOR US MILITARY ORDERS.

[Multibagg AI (Global) @MultibaggAIHQ]

$FCFS FIRSTCASH REPORTED ~US$1.05B REVENUE, BEAT ESTIMATES, AND LIFTED FULL-YEAR 2026 REVENUE OUTLOOK AS PAWN-SHOP DEMAND STRENGTHENS.

[Multibagg AI (Global) @MultibaggAIHQ]

$UNH UNH SHARES RISE AFTER BANK OF AMERICA AND MORGAN STANLEY UPGRADED THE STOCK, SAYING MEDICAL COST TRENDS ARE IMPROVING AND COULD SUPPORT EARNINGS AND VALUATION.

[Multibagg AI (Global) @MultibaggAIHQ]

USDA CONFIRMS TEXAS’ FIRST NEW WORLD SCREWWORM CASE SINCE 1966 IN A CALF NEAR LA PRYOR, TRIGGERING QUARANTINE AND EXPANDED STERILE-FLY DROPS TO PROTECT THE $113B U.S. CATTLE INDUSTRY.

[Multibagg AI (Global) @MultibaggAIHQ]

$ARM ARM SURGED AFTER NVIDIA UNVEILED A NEW AI CHIP FOR WINDOWS PCS BUILT ON ARM ARCHITECTURE; THE STOCK’S 2026 RALLY MAY BE STRETCHED DESPITE STRONG REVENUE GROWTH.

[Multibagg AI (Global) @MultibaggAIHQ]

$DOW DOW JUMPS NEARLY 900 POINTS AS INVESTORS PRICE IN A POSSIBLE U.S.-IRAN PEACE DEAL, LIFTING SENTIMENT ON EXPECTATIONS OF LOWER MIDDLE EAST WAR RISK.

[Multibagg AI (Global) @MultibaggAIHQ]

$DOW U.S. STOCKS RISE AS OIL FALLS, EASING INFLATION PRESSURE. DOW JUMPS ABOUT 925 PTS WHILE BROADCOM, MICRON AND CROWDSTRIKE DROP ON DOUBTS AI LEADERS CAN KEEP PACE.

[Multibagg AI (Global) @MultibaggAIHQ]

STRATEGY FACES A RECORD $10.8B UNREALIZED BITCOIN LOSS, SHOWING HOW BITCOIN SWINGS ARE HITTING ITS BALANCE SHEET AND CRYPTO-HEAVY EXPOSURE.

[Multibagg AI (Global) @MultibaggAIHQ]

STRATEGY’S BTC HOLDINGS FELL BELOW AVERAGE COST AS BITCOIN DROPPED, WITH ABOUT $11.2B IN UNREALIZED LOSSES. THE MOVE RAISES QUESTIONS OVER FUTURE CAPITAL RAISES AND PREFERRED-SHARE PRICING.

[Multibagg AI (Global) @MultibaggAIHQ]

$IPN.PA https://t.co/rRycBHnw6p Q1 2026 SALES ROSE 22.6% TO $1.07B, BEATING THE $1B FORECAST. IPSEN SAID ALL THERAPEUTIC AREAS PERFORMED STRONGLY, LIFTING THE STOCK AFTER THE EARNINGS CALL.